2017
DOI: 10.1016/j.ijpharm.2017.07.084
|View full text |Cite
|
Sign up to set email alerts
|

Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(8 citation statements)
references
References 43 publications
0
8
0
Order By: Relevance
“…One exciting potential use of patient-derived enteroids is to evaluate the effectiveness of personalized medicine, such as precision chemotherapy for cancer patients. Roy et al successfully evaluated the effects of Mitomycin-C, 5-Fluorouracil (5-FU), Irinotecan, Oxaliplatin, Doxorubicin, and Paclitaxel on peritoneal metastases using enteroids (Roy et al, 2017 ). Enteroids have also been used to model various intestinal physiology and disease processes (Table 2 ).…”
Section: Lessons Learned From Studies Of Other Enteropathogensmentioning
confidence: 99%
“…One exciting potential use of patient-derived enteroids is to evaluate the effectiveness of personalized medicine, such as precision chemotherapy for cancer patients. Roy et al successfully evaluated the effects of Mitomycin-C, 5-Fluorouracil (5-FU), Irinotecan, Oxaliplatin, Doxorubicin, and Paclitaxel on peritoneal metastases using enteroids (Roy et al, 2017 ). Enteroids have also been used to model various intestinal physiology and disease processes (Table 2 ).…”
Section: Lessons Learned From Studies Of Other Enteropathogensmentioning
confidence: 99%
“…Adequate comparative clinical studies will be difficult to perform. A more representative in-vitro model of peritoneal metastases of ovarian cancer with tumor-derived organoids (80,81) may eventually contribute to determining the role of hyperthermia in intraoperative intraperitoneal chemotherapy with taxanes.…”
Section: Resultsmentioning
confidence: 99%
“…The use of organoids to study peritoneal metastases is far behind that of other cancer systems. Only a few studies have recently been reported, usually involving very few patients and/or organoids that were generated following transplantation of human biopsies in mice [ 136 , 137 , 138 ]. Furthermore, in some cases the so-called organoids were in fact short-lasting primary heterogenous cultures from ovarian or gastric ascites-derived metastases [ 139 , 140 , 141 ].…”
Section: Organoids As a Platform For Screening Assaysmentioning
confidence: 99%